Cargando…

Nonsmoking and Nondrinking Oral Squamous Cell Carcinoma Patients: A Different Entity

OBJECTIVE: Our goal was to analyze the demographic and pathologic characteristics as well as prognosis in nonsmoking and nondrinking (NSND) oral squamous cell carcinoma (SCC) patients compared with typical oral SCC patients. PATIENTS AND METHODS: A total of 353 patients were retrospectively enrolled...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhan, Du, Wei, Zhang, Xu, Chen, Defeng, Fang, Qigen, He, Yuezhong, Yang, Yang, Li, Ding, Fan, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273760/
https://www.ncbi.nlm.nih.gov/pubmed/34262853
http://dx.doi.org/10.3389/fonc.2021.558320
_version_ 1783721432118722560
author Yang, Zhan
Du, Wei
Zhang, Xu
Chen, Defeng
Fang, Qigen
He, Yuezhong
Yang, Yang
Li, Ding
Fan, Jie
author_facet Yang, Zhan
Du, Wei
Zhang, Xu
Chen, Defeng
Fang, Qigen
He, Yuezhong
Yang, Yang
Li, Ding
Fan, Jie
author_sort Yang, Zhan
collection PubMed
description OBJECTIVE: Our goal was to analyze the demographic and pathologic characteristics as well as prognosis in nonsmoking and nondrinking (NSND) oral squamous cell carcinoma (SCC) patients compared with typical oral SCC patients. PATIENTS AND METHODS: A total of 353 patients were retrospectively enrolled and divided into two groups: the NSND group and the current smoking/current drinking (CSCD) group. Demographic, pathologic, and molecular data were compared between the two groups. The main research endpoints were locoregional control (LRC) and disease-specific survival (DSS). RESULTS: In the NSND group, 16.3%, 41.9%, and 53.5% of patients were aged no more than 40 years, were female, and had an educational background of high school or above compared to 3.7%, 6.0%, and 38.2% of patients in the CSCD group, respectively. A total of 15.1% of the NSND patients had SCC of the lower gingiva and floor of the mouth, which was lower than the 35.6% of patients in the CSCD group. CSCD patients were likely to have an advanced disease stage (48.7% vs 32.5%, p=0.042) and poorly differentiated cancer (26.6% vs 16.3%, p=0.042). The NSND patients had a mean Ki-67 index of 24.5%, which was lower than the mean of 35.7% in the CSCD patients. The two groups had no HPV infection and similar p16 expression (4.7% vs 10.1%, p=0.132), but there was higher expression of p53 (38.6% vs 17.4%, p<0.001) and p63 (59.9% vs 29.1%, p<0.001) in the CSCD group. The 5-year LRC rates for NSND patients and CSCD patients were 48% and 38%, respectively, and the difference was significant (p=0.048). The 5-year DSS rates for NSND patients and CSCD patients were 56% and 39%, respectively, and the difference was significant (p=0.047). Further, a Cox model confirmed the independence of smoking and drinking status for affecting LRC and DSS. CONCLUSION: NSND oral SCC patients are a different entity. HPV infection has a limited role in carcinogenesis in NSND patients, and p16 expression is associated with worse locoregional control.
format Online
Article
Text
id pubmed-8273760
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82737602021-07-13 Nonsmoking and Nondrinking Oral Squamous Cell Carcinoma Patients: A Different Entity Yang, Zhan Du, Wei Zhang, Xu Chen, Defeng Fang, Qigen He, Yuezhong Yang, Yang Li, Ding Fan, Jie Front Oncol Oncology OBJECTIVE: Our goal was to analyze the demographic and pathologic characteristics as well as prognosis in nonsmoking and nondrinking (NSND) oral squamous cell carcinoma (SCC) patients compared with typical oral SCC patients. PATIENTS AND METHODS: A total of 353 patients were retrospectively enrolled and divided into two groups: the NSND group and the current smoking/current drinking (CSCD) group. Demographic, pathologic, and molecular data were compared between the two groups. The main research endpoints were locoregional control (LRC) and disease-specific survival (DSS). RESULTS: In the NSND group, 16.3%, 41.9%, and 53.5% of patients were aged no more than 40 years, were female, and had an educational background of high school or above compared to 3.7%, 6.0%, and 38.2% of patients in the CSCD group, respectively. A total of 15.1% of the NSND patients had SCC of the lower gingiva and floor of the mouth, which was lower than the 35.6% of patients in the CSCD group. CSCD patients were likely to have an advanced disease stage (48.7% vs 32.5%, p=0.042) and poorly differentiated cancer (26.6% vs 16.3%, p=0.042). The NSND patients had a mean Ki-67 index of 24.5%, which was lower than the mean of 35.7% in the CSCD patients. The two groups had no HPV infection and similar p16 expression (4.7% vs 10.1%, p=0.132), but there was higher expression of p53 (38.6% vs 17.4%, p<0.001) and p63 (59.9% vs 29.1%, p<0.001) in the CSCD group. The 5-year LRC rates for NSND patients and CSCD patients were 48% and 38%, respectively, and the difference was significant (p=0.048). The 5-year DSS rates for NSND patients and CSCD patients were 56% and 39%, respectively, and the difference was significant (p=0.047). Further, a Cox model confirmed the independence of smoking and drinking status for affecting LRC and DSS. CONCLUSION: NSND oral SCC patients are a different entity. HPV infection has a limited role in carcinogenesis in NSND patients, and p16 expression is associated with worse locoregional control. Frontiers Media S.A. 2021-06-28 /pmc/articles/PMC8273760/ /pubmed/34262853 http://dx.doi.org/10.3389/fonc.2021.558320 Text en Copyright © 2021 Yang, Du, Zhang, Chen, Fang, He, Yang, Li and Fan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yang, Zhan
Du, Wei
Zhang, Xu
Chen, Defeng
Fang, Qigen
He, Yuezhong
Yang, Yang
Li, Ding
Fan, Jie
Nonsmoking and Nondrinking Oral Squamous Cell Carcinoma Patients: A Different Entity
title Nonsmoking and Nondrinking Oral Squamous Cell Carcinoma Patients: A Different Entity
title_full Nonsmoking and Nondrinking Oral Squamous Cell Carcinoma Patients: A Different Entity
title_fullStr Nonsmoking and Nondrinking Oral Squamous Cell Carcinoma Patients: A Different Entity
title_full_unstemmed Nonsmoking and Nondrinking Oral Squamous Cell Carcinoma Patients: A Different Entity
title_short Nonsmoking and Nondrinking Oral Squamous Cell Carcinoma Patients: A Different Entity
title_sort nonsmoking and nondrinking oral squamous cell carcinoma patients: a different entity
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273760/
https://www.ncbi.nlm.nih.gov/pubmed/34262853
http://dx.doi.org/10.3389/fonc.2021.558320
work_keys_str_mv AT yangzhan nonsmokingandnondrinkingoralsquamouscellcarcinomapatientsadifferententity
AT duwei nonsmokingandnondrinkingoralsquamouscellcarcinomapatientsadifferententity
AT zhangxu nonsmokingandnondrinkingoralsquamouscellcarcinomapatientsadifferententity
AT chendefeng nonsmokingandnondrinkingoralsquamouscellcarcinomapatientsadifferententity
AT fangqigen nonsmokingandnondrinkingoralsquamouscellcarcinomapatientsadifferententity
AT heyuezhong nonsmokingandnondrinkingoralsquamouscellcarcinomapatientsadifferententity
AT yangyang nonsmokingandnondrinkingoralsquamouscellcarcinomapatientsadifferententity
AT liding nonsmokingandnondrinkingoralsquamouscellcarcinomapatientsadifferententity
AT fanjie nonsmokingandnondrinkingoralsquamouscellcarcinomapatientsadifferententity